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ABSTRACT
Background: Non-Hodgkin lymphoma are a group of lymphoid neoplasms originating from the proliferation of precur-
sors or mature, T, B and/or NK lymphocytes. T-Zone lymphoma (TZL) is characterized as an indolent lymphoma due to 
its slow progression and poor chemotherapy’s response. Dogs affected by this neoplasm may live for many years without 
clinical signs and are often underdiagnosed. The aim of this study was to report a TZL case in a 9-year-old male mixed 
breed dog, submitted to clinical follow-up and chemotherapy.
Case: A 9-year-old male mixed-breed dog was presented due to the observation of an increased left mandibular lymph 
node. The previous cytological examination was suggestive of reactive hyperplasia and histopathological examination, 
by incisional biopsy, compatible with lymphocytic low-grade lymphoma. Physical examination revealed enlarged and 
firm left mandibular lymph node and adequate physical condition. A cytological examination was performed on the 
mandibular and both popliteal lymph nodes and revealed many small lymphocytes with hyperchromatic chromatin, rarely 
evident nucleolus and whose cytoplasm often projected in the form of a “hand-mirror” or “comet tail”, compatible with 
lymphocytic lymphoma (low grade) and suggestive of TZL, in the three assessed lymph nodes. The histopathological and 
immunohistochemical examination, of the mandibular lymph node were chosen to confirm the diagnosis. In histopathology 
it was observed that 40% of the sample contained a monotonous cell population, composed by small lymphocytes, with 
some presenting “hand-mirror” morphology. Two mitotic figures were evidenced per field of high magnification (40x), 
inferring a low-grade disease. Immunohistochemical analysis revealed neoplastic proliferation with immunolabeling of 
CD3 lymphocytes and positivity for Ki-67 in 48% of neoplastic cells, but negative for CD20, CD79a, CD45, MUM-1 and 
PAX-5. Although there is no consensus about requirements and treatment’s efficacy, it has been chosen to treat the dog 
with chlorambucil, because of the elevated Ki-67 value. The patient obtained a free-progression interval higher than 820 
days from the earlier investigations of lymphadenopathy, with excellent quality of life and no side effects related to the 
use of chlorambucil.
Discussion: Although TZL is a common subtype of lymphoproliferative disease in dog, it is still underdiagnosed. The 
TZL diagnosis can be suggested by cytology, from the disclosures in neoplastic cells of cytoplasmic projections, recog-
nized as a “hand-mirror” or “comet tail”, corroborated with the present case, however the histopathology is confirmatory. 
Immunohistochemistry in which the neoplasm cells showed a positive immunolabeling for CD3 and negative for CD79a, 
CD20, CD45, MUM1 and PAX5, as evidenced in this report, confirming the T-cell origin. According to the literature, 
lymphomas composed by small clear cells and cytoplasm projecting by cytology, immunolabeling CD3 and CD25 posi-
tive and CD45 negative are, together, findings that confirm TZL. The biological behaviour of indolent lymphoma is still 
largely unknown, however the prognosis of dogs, with indolent lymphoma of T or B cells, seems to be favourable. Studies 
showed different median survival times, such as 760 days and 4.4 years. In the present case, the dog survived more than 
820 days, confirming the good prognosis and indolent behaviour. Aggressive chemotherapy protocols are not necessary 
for such cases and the treatment with chlorambucil, without the association of prednisolone, has been well tolerated by 
the patient, which showed no side effects until the moment.
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INTRODUCTION
The current classification of non-Hodgkin 
lymphoma divides them into lymphomas of precursor 
cells (lymphoblastic) or mature cells (which include 
several subtypes). It also brings the concept of indolent 
lymphomas, represented by the T-zone lymphoma 
(TZL), and three B-cell lymphomas: marginal zone 
lymphoma (MZL), follicular lymphoma (FL) and 
mantle cell lymphoma (MCL) [1,10]. TZL is a rare 
clinical entity in humans, but apparently common 
in dogs, representing 5-15% of all lymphomas in 
this species [1,7,12]. Information about its biological 
behaviour and treatment are even more scarce than 
for other human’s indolent lymphomas, and the dog 
may represent a possible experimental model for un-
derstanding this disease. According to Valli et al. [10], 
TZL is characterized by cellular proliferation among 
the follicles, being composed of a homogeneous po-
pulation of small T lymphocytes (CD3+), with small 
nuclear indentations, unapparent nucleoli, moderate 
and pale cytoplasm and lack of CD45 (panleukocyte) 
immunolabeling. In a study performed in France, 
63.8% (388/608) of canine malignant lymphoma 
cases were B-cell lymphoma and 36.2% (215/608) 
were T-cell lymphoma, and the TZL was cytologi-
cally characterized by small cells, round or slightly 
irregular small nuclei and extended, unipolar and pale 
cytoplasm (“hand mirror” morphology) [5].
The objective of this study was to report a 
case of TZL in a mixed breed dog, in view to increase 
the knowledge about the biological behaviour of this 
pathology, which can be extrapolated to other species, 
including humans.
CASE
A 9-year-old male mixed-breed dog, weighing 
10.3 kg, was referred due to the observation of an in-
creased left mandibular lymph node, with cytological 
examination suggestive of reactive hyperplasia and 
histopathological examination (incisional biopsy) 
compatible with lymphocytic low-grade lymphoma. 
The dog was under treatment with metronomic lomus-
tine1, at a dose of 2.8 mg/m2 every 48 h, for approxi-
mately 60 days. Prednisolone2 had also been used, at 
a dose of 2 mg/kg every 24 h, for 7 days, followed by 
1 mg/kg every 24 h for over 7 days and 1 mg/kg every 
48 h, for 7 more days. Physical examination revealed 
adequate physical condition and mental state, body 
score 6 (1 - 9), a moderate increase in the volume of 
the left mandibular lymph node, of firm consistency, 
slightly fixed.
Complementary exams were performed, which 
included complete blood count, serum biochemistry 
(alanine aminotransferase, alkaline phosphatase, 
creatinine, urea, total protein, albumin, globulin, total 
cholesterol, blood glucose and triglycerides), thoracic 
radiography and abdominal ultrasound. Complete 
blood count was within normal range but biochemical 
tests revealed a moderate increase in the values of 
alanine-aminotransferase (128 UI/L; Ref: 15-58 UI/L), 
alkaline phosphatase (543 UI/L; Ref: 20-156 UI/L), 
total protein (8.45 g/dL; Ref: 5.4-7.1 g/dL), globu-
lins (5.17 g/dL; Ref: 2.7-4.4 g/dL) and triglycerides 
(130 mg/dL; Ref: 20-112 mg/dL). Radiographs were 
unremarkable but the abdominal ultrasound showed a 
gallbladder with thin wall and regular contour, popu-
lated by anechoic content with amorphous echogenic 
material in suspension, in addition to hyperechogenic 
points deposited at the bottom (bile sludge), compatible 
with mild cholestasis and formation of biliary con-
cretions. Spleen size, contour and echogenicity were 
preserved, but there was two hypoechogenic nodules, 
showing no distortion of the capsule of the organ, me-
asuring 0.94 x 0.83 cm and 0.34 x 0.30 cm, compatible 
with lymphoid nodular hyperplasia, extramedullary 
hematopoiesis or neoplastic process.
Cytological examination was performed on 
the left mandibular and both popliteal lymph nodes, 
sampled by fine needle aspiration, fixed and stained 
with Diff-Quick method. A histopathological review 
was carried out from the fragment previous removed 
by incisional biopsy of the left mandibular lymph 
node, along with immunohistochemical staining 
for CD33, CD79a3, CD203, CD453, MUM13, PAX53 
and Ki-673. The cytological examination allowed 
the identification of many small lymphocytes with 
hyperchromatic chromatin, rarely evident nucleolus 
and whose cytoplasm often projected in the form of a 
“hand-mirror” or “comet tail”, besides the small num-
ber of erythrocytes, neutrophils and rare plasmocytes, 
compatible with lymphocytic lymphoma (low grade) 
and suggestive of TZL, in the three assessed lymph 
nodes (Figure 1). In the first consultation, splenic as-
pirates were not taken due to resistance of the person 
responsible for the dog, and the patient was considered 
in disease stage III [11].
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In the histopathological examination of the 
mandibular lymph node, approximately 40% of the 
sample contained a monotonous cell population, 
composed by small lymphocytes, sometimes with 
discrete nuclear indentations, with multiple nucleoli, 
moderate and pale cytoplasm, with some presenting 
projections (as a “hand-mirror” or “comet tail”). 
Two mitotic figures were evidenced per field of high 
magnification (40x), inferring a low-grade disease 
(Figure 2A). Immunohistochemical staining revealed 
neoplastic proliferation with immunolabeling of CD33 
lymphocytes (T) [Figure 2B] and a positivity for Ki-673 
in 48% of neoplastic cells (Figure 2C). There was no 
immunolabeling for the remaining antibodies (CD203, 
CD453, CD79a3, MUM13, PAX53) [Figure 2D]. It was 
concluded that the immunohistochemical and morpho-
logical profile favored the TZL diagnosis.
Considering the persistent abnormalities in the 
liver and biliary tract, oral treatment was instituted with 
ursodeoxycholic acid4 at a dose of 5 mg/kg every 12 
h, along with food, omega-3 supplementation5 (1000 
mg/day), Hepvet®6 (supplement based on amino acids, 
minerals and vitamin B complex) and silymarin7 (20 
mg/kg) once a day for 60 days. Lomustine1 was repla-
ced by chlorambucil8 at a dose of 4 mg/m2, in alternate 
days, with re-checks every 2 months. Ultrasonographic 
follow-up was also performed and the spleen nodules 
were still hypoechoic, measuring 0.9 x 0.8 cm and 
0.3 x 0.3 cm, six months after the diagnosis. Fourteen 
months after the diagnosis, it was possible to identify 
only one nodule, this time with mixed echogenicity, 
measuring 0.7 x 0.6 cm. Novel cytological samples 
were taken from the spleen, mandibular and popliteal 
lymph nodes. Spleen aspirates revealed a reactional 
hyperplasia, characterized by a mixed lymphoid po-
pulation with predominance of small lymphocytes 
and few plasma cells. No signs of malignancy were 
observed in these lymphoid cells. The left mandibular 
and both popliteal lymph nodes aspirates allowed the 
identification, once more, of the indolent neoplastic 
process. Up to the moment, 820 days after the first 
investigation of lymphadenopathy, and with approxi-
mately 790 days of treatment with chlorambucil8, the 
patient is otherwise healthy, without any side effects 
related to chemotherapy and without signs of progres-
sion of its indolent lymphoma.
DISCUSSION
In the dog 60-70% of lymphomas are derived 
from B cells and approximately 75% are considered 
high-grade lymphomas. A higher incidence is observed 
in Boxer, Bull Masttiff, Basset Hound, São Bernardo 
and Bulldogs, with an average age of 6-9 years [11]. 
The incidence of each histological subtype is varia-
ble according to the literature, but the diffuse B-cell 
lymphoma is the most frequent (50%), followed by 
peripherical-T-cell lymhpoma not otherwise specified 
(PT-NOS) (15%) [12], which includes TZL [1], as evi-
denced in this report, which may represent 5-15% of all 
lymphomas in dog and 30-40% of indolent lymphomas 
[7,12]. Considering only the indolent lymphomas, 
Valli et al. [10], in the United States, observed greater 
representativeness of Golden Retriever, Labrador and 
Rottweiler, also commonly affected by other forms of 
lymphoma [12]. Mixed-breed dogs, as in the present 
case, represented 10% of the cases of indolent lympho-
mas. [10]. However, unlike the present report, which is 
a male dog, the females were more affected by indolent 
lymphomas, regardless of reproductive status, while 
age ranged from 1.5 - 16 years, with an average of 9 
years (7.7 years for MZL, 8 years for MCL, 11 years 
for FL and 8.9 years for TZL) [10], coinciding with 
the patient’s age.
The most frequent clinical presentation of 
indolent lymphomas is the chronic lymphadenopathy, 
as evidenced in this case, although patients may also 
be presented with inappetence, anorexia, weight loss 
and fever [9]. TZL are exclusive of nodal lymphomas 
and similar presentations in other organs may represent 
other forms of PT-NOS. Indolent lymphomas are also 
frequent in the spleen, mainly MZL and MCL, which 
Figure 1. Cytological smear of mandibular lymph node of a 9-year-old 
mixed-breed dog diagnosed with T-zone lymphoma. Small lymphocytes are 
observed with cytoplasm often projecting in the form of a “hand-mirror” 
or “comet tail” (arrow). Associated with the T-zone lymphocytes there are 
few neutrophils and plasmocytes [Diff-Quick; 40x].
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represents the most common lymphoma subtypes in 
this organ (39.3% and 32.1% of cases, respectively).
Indolent lymphomas must be differentiated 
from lymphoid hyperplasia and other lymphomas 
varying from small to intermediary cells and reduced 
mitotic index [9, 10]. The TZL diagnosis can be sug-
gested by cytology, from the disclosures in neoplastic 
cells of a cytoplasmic projection, recognized as a 
“hand mirror” or “comet tail “. In a retrospective stu-
dy, 20 cases of TZL were cytologically characterized 
by small cells, round or slightly irregular small nuclei 
and extended, unipolar and pale cytoplasm (“hand 
mirror” morphology) [5]. However, as noted in this re-
port, the retrieval of such information may be subject 
to the sample and/or experience of the pathologist. The 
histopathology is, however, confirmatory because it 
highlights the neoplastic proliferation adjacent to the 
germinal centers (eccentric), leading to the collapse of 
lymphoid follicles, while the proliferation around the 
follicle, into a concentric pattern, refers to the MZL 
[12]. This might not be found in incisional biopsies. 
Immunophenotyping provides greater reliability 
to the diagnosis, which may be performed by flow 
cytometry, unavailable where this study was carried 
out, and immunohistochemistry, particularly useful in 
samples of incisional biopsy, as evidenced by Flood-
-Knapik et al. [1] and also in this report, in which 
the neoplasm showed a positive immunolabeling for 
CD3, confirming the T-cell origin, and negative for 
CD79a and CD20 (expressed in B lymphocytes and 
inconstant in plasmocytes), CD45 (expressed in all 
leukocytes but absent in TZL), MUM1 (expressed in 
Figure 2. Histopathological and immunohistochemical photomicrographs of mandibular lymph nodes of a 9-year-old mixed-breed dog, diagnosed with 
T-zone lymphoma. A- Proliferation of small malignant lymphocytes, presenting the core equating to 1.0-1.5 times the diameter of the erythrocytes [HE; 
40x]. B- Immunolabeling for CD3, confirming the neoplastic proliferation of T lymphocytes, marked in brown [Ac CD3; 40x]. C-Immunolabeling for 
Ki-67 in 48% of neoplastic cells [Ac Ki-67; 40x]. D- Negative immunolabeling for CD45 [Ac CD45; 40x].
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plasmocytes and inconstant in B lymphocytes) and 
PAX5 (expressed in B lymphocytes) [7,12]. According 
to recent studies, lymphomas with a small clear cell 
appearance and “hand mirror” morphology by cyto-
logy [2], immunolabeling CD3 and CD25 positive 
and CD45 negative [2,3] are, together, findings that 
confirm TZL.
In one study with 66 dogs diagnosed with in-
dolent lymphoma, it was observed that 72.7% (48/66) 
were represented by MZL (35 nodal and 13 splenic), 
15.2% (10/66) by TZL (all in lymph nodes), 7.6% 
(5/66) by nodal FL and 4.6% (3/66) by splenic MCL 
[10]. However, in one retrospective study, including 
75 dogs with lymphoma whose histopathological 
descriptions presented small or intermediate cells 
and/or reduced mitotic index, it was observed that the 
TZL was the most frequent, representing 61.7% of the 
cases (37/75), followed by MZL (25%), FL (6.7%) 
and MCL (1.7%), while the remaining diagnoses were 
T-cell rich B-cell lymphoma (3.3%) and lymphocytic 
lymphoma (1.7%) [1]. In the same study, immunophe-
notyping proved to be useful by allowing change in the 
diagnosis in 20.4% of cases (particularly in MZL for 
TZL), and allowed the final diagnosis of nine TZLs, 
five MZL and one FL. Despite the reduced mitotic in-
dex, compatible with low-grade lymphoma, evidenced 
in the cytology and histopathology, in this case, the 
Ki-67 value was higher than the mean observed for 
indolent lymphomas in the study of Flood-Knapik et 
al. [1], who obtained an average of 21% of stained 
neoplastic cells (17.6% for the TZL, 20% for MZL 
and 59% for FL).
The biological behaviour of indolent lympho-
ma is still largely unknown, however the prognosis of 
dogs with indolent lymphoma of T or B cells, seems 
to be favourable [1,2,9,10]. A study performed with 51 
dogs diagnosed with TZL, showed 760 days of median 
overall survival [2]. In another study [1], it was obser-
ved a median of 4.4 years for indolent lymphomas, and 
no statistical difference was observed in the survival of 
dogs with TZL (33.5 months) or MZL (21.2 months) [P 
= 0.5]. The stage of the disease, including bone marrow 
infiltration, mitotic index, cell size, immunophenotype, 
value of Ki-67 and treatment did not influence the 
survival, however, lymphocytosis above 9212 cells/μL 
had an impact on prognosis, resulting in a median of 
15.4 months, while the median of the remaining dogs 
was not achieved (P = 0.05).
Treatment does not seem to influence the 
survival and quality of life of dogs affected by indo-
lent lymphomas [10]. In the study of Flood-Knapik 
et al. [1], no difference was observed in the survival 
of dogs with indolent lymphoma which received no 
treatment (52.4 months), prednisone (33.5 months) 
or chemotherapy (P = 0.07), with chlorambucil and 
prednisolone (median not reached) or combination of 
prednisolone, cyclophosphamide, vincristine, doxoru-
bicin and L-asparaginase (21.6 months) [P = 0.06]. It is 
a slow-progressive disease and the effect of systemic 
treatment should be determined by future studies [1]. 
There is no consensus and treatment may be indica-
ted, at the discretion of the clinician, in the presence 
of lymphocytosis, advanced stage, high mitotic index 
or percentage of expression of Ki-67, choosing the 
monotherapy with prednisolone, its association with 
alkylating agents, or even protocols with combination 
of multiple drugs [10]. Although bone marrow aspirates 
were not taken, the patient of the reported case was 
considered in stage III. It was chosen to initiate the 
treatment due to the disease advanced stage (involve-
ment of at least three lymph nodes) and high growth 
fraction evidenced by Ki-67, using the chlorambucil 
as a single agent due to hepatic abnormalities showed 
in the serum biochemistry and ultrasound, probably 
related to the vacuolar hepatitis, by obesity and use of 
glucocorticoids. The patient showed no side effects and 
remains in follow-up every 2 months, with an excellent 
quality of life.
TZL is a common subtype of lymphoprolifera-
tive diseases in dogs, however it is still underdiagnosed. 
TZL must be suggested by cytology, although the 
definitive diagnosis is conditioned to histopathology, 
and may receive support from immunohistochemistry 
or flow cytometry. TZL presents a good prognosis and 
an indolent behaviour, as shown in the described case, 
despite the high Ki-67 value, resulting in a high period 
free of progression and survival. Aggressive chemothe-
rapy protocols are not necessary for such cases and the 
treatment with chlorambucil, without the association 
of prednisolone, has been well tolerated by the patient, 
which showed no side effects until the moment.
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